Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
Fast Prediction of Binding Affinities of SARS-CoV-2 Spike Protein and Its Mutants with Antibodies through Intermolecular Interaction Modeling-Based Machine Learning | The Journal of Physical Chemistry B
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Science Translational Medicine
Guidance for surveillance of SARS-CoV-2 variants
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail | Nature Microbiology
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? - The Lancet Respiratory Medicine
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses | Science Immunology
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike | Nature
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Science Translational Medicine
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant | The Journal of Physical Chemistry Letters
Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain - ScienceDirect
Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview | ACS Infectious Diseases
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant | The Journal of Physical Chemistry Letters
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses | Science Immunology
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant | Clinical Microbiology Reviews
COVID-19 Antibody Tests and Their Limitations | ACS Sensors
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity | Science Advances
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant - ScienceDirect
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies - ScienceDirect
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite - ScienceDirect
Fast Prediction of Binding Affinities of SARS-CoV-2 Spike Protein and Its Mutants with Antibodies through Intermolecular Interaction Modeling-Based Machine Learning | The Journal of Physical Chemistry B
Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants - Ong - 2023 - Journal of Medical Virology - Wiley Online Library
Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam | BMC Infectious Diseases | Full Text
